Condition | AORa | 95% CIb | P-value | Incidence | ||
---|---|---|---|---|---|---|
Hypocalcemia (Calcium ≤ 2.14 mmol/L) | ||||||
Treatment | +/nd | % | ||||
Treatmentc | 0.09 | |||||
CA vs. CON | 0.44 | 0.15 - 1.31 | 0.14 | CA | 32/45 | 71.1 |
CA vs. NOR | 1.28 | 0.59 - 2.79 | 0.53 | CON | 37/43 | 86.1 |
CON vs. NOR | 2.89 | 1.10 - 7.65 | 0.03 | NOR | 63/96 | 65.6 |
Combined treatments | ||||||
Reduced CRET vs. NORe | 1.79 | 0.91 - 3.5 | 0.08 | |||
SLM (FA ≥ 0.6 mmol/L)f | ||||||
Treatment | 0.001 | |||||
CA vs. CON | 0.98 | 0.35 - 2.79 | 0.97 | CA | 36/45 | 80.0 |
CA vs. NOR | 3.95 | 1.71 - 9.15 | 0.001 | CON | 34/43 | 79.1 |
CON vs. NOR | 4.02 | 1.71 - 9.43 | 0.001 | NOR | 49/96 | 51.0 |
Combined treatments | ||||||
Reduced CRET vs. NOR | 3.98 | 2.05 - 7.76 | < 0.001 | |||
SCK (BHB ≥ 1.0 mmol/L [d 1–4] and BHB ≥ 1.4 mmol/L [d 12])g | ||||||
Treatment | 0.01 | |||||
CA vs. CON | 2.64 | 0.86 - 8.13 | 0.09 | CA | 39/45 | 86.6 |
CA vs. NOR | 4.19 | 1.60 - 11.0 | 0.003 | CON | 32/43 | 74.4 |
CON vs. NOR | 1.59 | 0.70 - 3.60 | 0.26 | NOR | 59/96 | 61.4 |
Combined treatments | ||||||
Reduced CRET vs. NOR | 2.49 | 1.27 - 4.91 | 0.008 |